Candel Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NORTHPOND VENTURES, LLC | 11/14/2024 | 1.94 M | $13.41 M | 0.00% | 6.05% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.13 M | $7.80 M | 100.00% | 3.52% |
| VANGUARD GROUP INC | 11/13/2024 | 946,265 | $6.56 M | 15.60% | 2.96% |
| STATE STREET CORP | 11/14/2024 | 492,005 | $3.41 M | 4.06% | 1.54% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 448,997 | $3.11 M | 12.85% | 1.40% |
| SANDS CAPITAL VENTURES, LLC | 11/13/2024 | 405,837 | $2.81 M | 0.00% | 1.27% |
| HALTER FERGUSON FINANCIAL INC. | 11/13/2024 | 304,539 | $2.11 M | 100.00% | 0.95% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 135,455 | $938,703 | 100.00% | 0.42% |
| CITADEL ADVISORS LLC | 11/14/2024 | 85,000 | $589,050 | 41.20% | 0.27% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 80,595 | $558,523 | 0.00% | 0.25% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 66,217 | $458,884 | -82.67% | 0.21% |
| MORGAN STANLEY | 11/14/2024 | 64,433 | $446,520 | 231.14% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 64,400 | $446,292 | 54.44% | 0.20% |
| HB WEALTH MANAGEMENT, LLC | 10/15/2024 | 56,658 | $392,640 | 100.00% | 0.18% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 46,777 | $324,165 | 0.00% | 0.15% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 44,978 | $311,700 | -17.39% | 0.14% |
| JANE STREET GROUP, LLC | 11/15/2024 | 40,000 | $277,200 | 100.00% | 0.12% |
| JANE STREET GROUP, LLC | 11/15/2024 | 32,794 | $227,262 | 174.20% | 0.10% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 30,261 | $209,709 | 66.04% | 0.09% |
| BARCLAYS PLC | 11/19/2024 | 28,688 | $199,000 | 327.10% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2024 | 25,600 | $177,408 | 79.02% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 23,600 | $163,548 | 3.96% | 0.07% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 22,838 | $158,000 | 356.67% | 0.07% |
| RHUMBLINE ADVISERS | 11/12/2024 | 22,455 | $155,605 | -2.31% | 0.07% |
| MML INVESTORS SERVICES, LLC | 11/15/2024 | 22,313 | $155,000 | -69.59% | 0.07% |
| VONTOBEL HOLDING LTD. | 10/16/2024 | 22,000 | $152,460 | 0.00% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 21,859 | $151,483 | -59.85% | 0.07% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 20,036 | $138,849 | 100.00% | 0.06% |
| ATOM INVESTORS LP | 11/14/2024 | 14,873 | $103,070 | 100.00% | 0.05% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 13,712 | $95,024 | -20.94% | 0.04% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2024 | 12,558 | $87,027 | 100.00% | 0.04% |
| JANNEY MONTGOMERY SCOTT LLC | 10/29/2024 | 11,665 | $81,000 | 0.43% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 10,825 | $75,017 | 100.00% | 0.03% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 10,741 | $74,435 | 0.76% | 0.03% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 10,660 | $73,874 | 0.00% | 0.03% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 10,349 | $71,719 | -15.44% | 0.03% |
| UBS GROUP AG | 11/14/2024 | 9,446 | $65,461 | 57.30% | 0.03% |
| JPMORGAN CHASE & CO | 11/08/2024 | 9,051 | $62,723 | -53.24% | 0.03% |
| FMR LLC | 11/13/2024 | 6,573 | $45,551 | 100.00% | 0.02% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 6,187 | $42,876 | -2.47% | 0.02% |
| ROYAL BANK OF CANADA | 11/14/2024 | 2,833 | $19,000 | 25.13% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 2,736 | $18,960 | 118.53% | 0.01% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 2,197 | $15,225 | 0.00% | 0.01% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 2,143 | $14,851 | 100.00% | 0.01% |
| AMERITAS INVESTMENT PARTNERS, INC. | 11/13/2024 | 1,941 | $13,451 | 0.00% | 0.01% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 1,700 | $12,000 | -90.00% | 0.01% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 11/14/2024 | 1,436 | $9,951 | 0.00% | 0.00% |
| AMALGAMATED BANK | 10/30/2024 | 686 | $5,000 | 0.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 101 | $700 | 100.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 10/24/2024 | 78 | $541 | 100.00% | 0.00% |
Candel Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 58 institutional investors and hedge funds held shares of Candel Therapeutics, Inc.. The most heavily invested institutionals were:
Northpond Ventures, LLC: 1.94 M
BlackRock Funding, Inc. /DE: 1.13 M
VANGUARD GROUP INC: 946,265
STATE STREET CORP: 492,005
GEODE CAPITAL MANAGEMENT, LLC: 448,997
Sands Capital Ventures, LLC: 405,837
20.91% of Candel Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 7.42 M shares in the last 24 months. This purchase volume represents approximately $64.03 M in transactions.